These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30712460)

  • 1. Identification of aberrant gene expression during breast ductal carcinoma
    Song G; He L; Yang X; Yang Y; Cai X; Liu K; Feng G
    J Int Med Res; 2020 Jan; 48(1):300060518815364. PubMed ID: 30712460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.
    Seth A; Kitching R; Landberg G; Xu J; Zubovits J; Burger AM
    Anticancer Res; 2003; 23(3A):2043-51. PubMed ID: 12894577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer.
    Elias EV; de Castro NP; Pineda PH; Abuázar CS; Bueno de Toledo Osorio CA; Pinilla MG; da Silva SD; Camargo AA; Silva WA; E Ferreira EN; Brentani HP; Carraro DM
    Oncotarget; 2016 Nov; 7(46):75672-75684. PubMed ID: 27708222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
    Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
    Asch HL; Winston JS; Edge SB; Stomper PC; Asch BB
    Breast Cancer Res Treat; 1999 May; 55(2):179-88. PubMed ID: 10481945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis.
    Rane SU; Mirza H; Grigoriadis A; Pinder SE
    Breast Cancer Res Treat; 2015 Aug; 153(1):101-21. PubMed ID: 26255059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.
    Nass SJ; Herman JG; Gabrielson E; Iversen PW; Parl FF; Davidson NE; Graff JR
    Cancer Res; 2000 Aug; 60(16):4346-8. PubMed ID: 10969774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.
    Helczynska K; Kronblad A; Jögi A; Nilsson E; Beckman S; Landberg G; Påhlman S
    Cancer Res; 2003 Apr; 63(7):1441-4. PubMed ID: 12670886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of the tumor microenvironment in breast cancer.
    Allinen M; Beroukhim R; Cai L; Brennan C; Lahti-Domenici J; Huang H; Porter D; Hu M; Chin L; Richardson A; Schnitt S; Sellers WR; Polyak K
    Cancer Cell; 2004 Jul; 6(1):17-32. PubMed ID: 15261139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in studies on in-situ and invasive ductal carcinoma].
    Zhang RJ; Niu Y; Gao YX
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):63-5. PubMed ID: 19489232
    [No Abstract]   [Full Text] [Related]  

  • 12. Ductal carcinoma in situ of the breast: histological classification and genetic alterations.
    van de Vijver MJ
    Recent Results Cancer Res; 1998; 152():123-34. PubMed ID: 9928552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 expression in normal, hyperplastic and malignant breast tissues.
    Wang X; Mori I; Tang W; Nakamura M; Nakamura Y; Sato M; Sakurai T; Kakudo K
    Breast Cancer; 2002; 9(3):216-9. PubMed ID: 12185332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.
    Munn KE; Walker RA; Menasce L; Varley JM
    Br J Cancer; 1996 Nov; 74(10):1578-85. PubMed ID: 8932338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.
    Barham W; Chen L; Tikhomirov O; Onishko H; Gleaves L; Stricker TP; Blackwell TS; Yull FE
    BMC Cancer; 2015 Sep; 15():647. PubMed ID: 26424146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor.
    Lawrence JA; Merino MJ; Simpson JF; Manrow RE; Page DL; Steeg PS
    Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):29-35. PubMed ID: 9456240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
    Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
    Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade.
    Sowter HM; Ferguson M; Pym C; Watson P; Fox SB; Han C; Harris AL
    J Pathol; 2003 Dec; 201(4):573-80. PubMed ID: 14648660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
    Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
    Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.